Literature DB >> 35194189

Deneddylation of PML/RARα reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate APL.

Xuejing Shao1, Yingqian Chen1, Aixiao Xu1, Danyan Xiang1, Wei Wang1, Wenxin Du1, Yunpeng Huang1, Xingya Zhang1, Minyi Cai1, Zhimei Xia1, Yi Wang2, Ji Cao1,3, Yan Zhang4, Bo Yang1, Qiaojun He1,3, Meidan Ying5,6,7.   

Abstract

Acute promyelocytic leukemia (APL) is driven by the oncoprotein PML/RARα, which destroys the architecture of PML nuclear bodies (NBs). PML NBs are critical to tumor suppression, and their disruption mediated by PML/RARα accelerates APL pathogenesis. However, the mechanisms of PML NB disruption remain elusive. Here, we reveal that the failure of NB assembly in APL results from neddylation-induced aberrant phase separation of PML/RARα. Mechanistically, PML/RARα is neddylated in the RARα moiety, and this neddylation enhances its DNA-binding ability and further impedes the phase separation of the PML moiety, consequently disrupting PML NB construction. Accordingly, deneddylation of PML/RARα restores its phase separation process to reconstruct functional NBs and activates RARα signaling, thereby suppressing PML/RARα-driven leukemogenesis. Pharmacological inhibition of neddylation by MLN4924 eradicates APL cells both in vitro and in vivo. Our work elucidates the neddylation-destroyed phase separation mechanism for PML/RARα-driven NB disruption and highlights targeting neddylation for APL eradication.
© 2022. The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35194189      PMCID: PMC9345999          DOI: 10.1038/s41418-022-00955-8

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   12.067


  63 in total

Review 1.  PML Nuclear Body Biogenesis, Carcinogenesis, and Targeted Therapy.

Authors:  Yuwen Li; Xiaodan Ma; Wenyu Wu; Zhu Chen; Guoyu Meng
Journal:  Trends Cancer       Date:  2020-06-08

Review 2.  Acute Promyelocytic Leukemia: A Paradigm for Oncoprotein-Targeted Cure.

Authors:  Hugues de Thé; Pier Paolo Pandolfi; Zhu Chen
Journal:  Cancer Cell       Date:  2017-11-13       Impact factor: 31.743

3.  Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure.

Authors:  Julien Ablain; Kim Rice; Hassane Soilihi; Aurélien de Reynies; Saverio Minucci; Hugues de Thé
Journal:  Nat Med       Date:  2014-01-12       Impact factor: 53.440

Review 4.  PML nuclear bodies: from architecture to function.

Authors:  Valérie Lallemand-Breitenbach; Hugues de Thé
Journal:  Curr Opin Cell Biol       Date:  2018-04-30       Impact factor: 8.382

Review 5.  Protein Phase Separation: A New Phase in Cell Biology.

Authors:  Steven Boeynaems; Simon Alberti; Nicolas L Fawzi; Tanja Mittag; Magdalini Polymenidou; Frederic Rousseau; Joost Schymkowitz; James Shorter; Benjamin Wolozin; Ludo Van Den Bosch; Peter Tompa; Monika Fuxreiter
Journal:  Trends Cell Biol       Date:  2018-03-27       Impact factor: 20.808

Review 6.  Protein neddylation and its alterations in human cancers for targeted therapy.

Authors:  Lisha Zhou; Wenjuan Zhang; Yi Sun; Lijun Jia
Journal:  Cell Signal       Date:  2018-01-10       Impact factor: 4.315

7.  Coexisting Liquid Phases Underlie Nucleolar Subcompartments.

Authors:  Marina Feric; Nilesh Vaidya; Tyler S Harmon; Diana M Mitrea; Lian Zhu; Tiffany M Richardson; Richard W Kriwacki; Rohit V Pappu; Clifford P Brangwynne
Journal:  Cell       Date:  2016-05-19       Impact factor: 41.582

Review 8.  Protein neddylation: beyond cullin-RING ligases.

Authors:  Radoslav I Enchev; Brenda A Schulman; Matthias Peter
Journal:  Nat Rev Mol Cell Biol       Date:  2015-01       Impact factor: 94.444

9.  PML is a ROS sensor activating p53 upon oxidative stress.

Authors:  Michiko Niwa-Kawakita; Omar Ferhi; Hassane Soilihi; Morgane Le Bras; Valérie Lallemand-Breitenbach; Hugues de Thé
Journal:  J Exp Med       Date:  2017-09-20       Impact factor: 14.307

10.  Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice.

Authors:  Edwige Voisset; Eva Moravcsik; Eva W Stratford; Amie Jaye; Christopher J Palgrave; Robert K Hills; Paolo Salomoni; Scott C Kogan; Ellen Solomon; David Grimwade
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

View more
  1 in total

Review 1.  Regulating the p53 Tumor Suppressor Network at PML Biomolecular Condensates.

Authors:  Magdalena C Liebl; Thomas G Hofmann
Journal:  Cancers (Basel)       Date:  2022-09-20       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.